At the 2012 VEITHsymposium, John R. Laird, MD, spoke on the mechanism and efficacy of the TruePath CTO Device (Boston Scientific) for crossing chronic total occlusion (CTO) lesions. Dr. Laird is a medical director and professor of medicine at UC Davis Vascular Center in Sacramento, California. His practice focuses on interventions for carotid artery disease, abdominal and thoracic aortic aneurysmal disease, renal artery disease, and peripheral artery disease. The TruePath CTO device features a diamond-coated distal tip that rotates at 13,000 revolutions per minute. The tip acts as a drill and can penetrate very hard calcific plaque. It comes as one unit, and allows easy setup. It is compatible with any support catheter. Vascular Disease Management spoke with Dr. Laird about the TruePath device, and he shared his thoughts on the most important message that vascular specialists.
“I think for all of us, it’s still a learning experience. We’re still trying to figure out where best this technology can be applied,” said Dr. Laird. “But like a lot of these intraluminal CTO devices, you have to be patient, you have to take your time, and you have to allow your device to do its work rather than trying to push hard and move quickly, or you’re going to end up subintimal like you would with any of the other standard guidewire techniques, so patience is required.”
View the video interview with Dr. Laird at “The TruePath CTO Device: An Interview With John R. Laird, MD.”